Fintel reports that on February 7, 2025, HC Wainwright & Co. initiated coverage of Vertical Aerospace (NYSE:EVTL) with a Buy ...

H.C. Wainwright initiated coverage of Vertical Aerospace (EVTL) with a Buy rating and $12 price target The company specializes in designing ...

H.C. Wainwright lowered the firm’s price target on Neurocrine (NBIX) to $185 from $190 and keeps a Buy rating on the shares. FY25 Ingrezza ...

H.C. Wainwright analyst Mike Colonnese reiterated the Buy rating on CleanSpark, Inc. (NASDAQ:CLSK), with a price forecast of ...

H.C. Wainwright analyst Mitchell S. Kapoor revised the price target on Alumis Inc (NASDAQ:ALMS) to $19.00, down from the previous target of $26.00, while retaining a Buy rating for the company's ...

Neurocrine Biosciences Q4 earnings topped forecasts, but revenue slightly missed. Analysts see Ingrezza's long-term growth ...

Would you like to be notified of the latest news and updates on the stock market?

Research analysts at StockNews.com initiated coverage on shares of DURECT (NASDAQ:DRRX – Get Free Report) in a report issued on Friday. The firm set a “sell” rating on the specialty pharmaceutical ...

In this article, we will discuss the 12 Best Healthcare Stocks to Buy According to Analysts. McKinsey reported that, since ...

CFO Gary Vecchiarelli reported that Q1 revenues grew 120% year-over-year to $162.3 million, driven by higher Bitcoin prices and increased production efficiency. Fleet efficiency improved to 17.59 ...